| |
 |
| |
|
|
Number of Gyrolab purchased |
 |
Amgen, Thousand Oaks, US
|
 |
|
 |
|
AstraZeneca, Södertälje, SWE and Charnwood, UK
More information: Application
report 206 
|
 |
|
|
|
Biogen-Idec, Cambridge, US
More information: Application
report 203 |
 |
|
|
|
| Bristol-Myers Squibb Company, Princeton, USA |
 |
|
|
|
| GE Healthcare Bio-Sciences, Uppsala, SWE |
 |
|
|
|
| GlaxoSmithKline, RTP, USA and Stevenage, UK |
 |
|
|
|
| HFL, Fordham, UK |
 |
|
|
|
MedImmune, Gaithersburg, US and Cambridge, UK
More information: Application
report 207
|
 |
|
|
|
| Merck, Westpoint, US |
 |
|
|
|
| MerckSerono, Fenil-sur-Corsier, CH |
 |
|
|
|
| National Research Centre for the Working Environment,
Denmark (AMI, Copenhagen, DK) |
 |
|
|
|
National Veterinary Institute, Uppsala, SWE
More information: Application
report 202 |
 |
|
|
|
| NovImmune, Geneva, CH |
 |
|
|
|
Novo Nordisk, Målöv, DK
More information: Application
report 204 |
 |
|
|
|
| Probiogen, Berlin, Germany |
 |
|
|
|
| Rentschler Biotechnologie, Laupheim, Germany |
 |
|
|
|
| Royal Institute of Technology, Stockholm, SWE |
 |
|
|
|
| Rudbeck Laboratory, Uppsala, SWE |
 |
|
|
|
| Veeda Clinical Research, Plymouth, UK |
 |
|
|
|
|
